After some delay, the Federal Trade Commission has approved Novo Holdings’ $16.5 billion acquisition of Catalent, a week following the European Commission’s go-ahead.
Now that …
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
PharmaSGP Holding SE / Key word(s): Dividend PharmaSGP Holding SE proposes an increased dividend of EUR 1.36 per share for 2023 18-Apr-2024 / 20:31 CET/CEST
Samsung Biologics disclosed Monday that it’s significantly expanding a 2022 pact with Novartis to help with the Swiss company’s biologics manufacturing. The original $81 million
Earlier menopause combined with higher risk of cardiovascular disease is linked to an increased risk of thinking and memory problems later, according to a new